Age is of influence on midazolam requirements in a paediatric intensive care unit

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 3, 2007, Pages 414-417

  De Gast Bakker, Dana Anne H ^a   Van Der Werff, Suzanne D ^a   Sibarani Ponsen, Renate ^a   Swart, Eleonora L ^a   Plötz, Frans B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Children; Mechanical ventilation; Midazolam; Paediatric intensive care; Sedation

Indexed keywords

CLONIDINE; FENTANYL; KETAMINE; MIDAZOLAM; MIDAZOLAM MALEATE; MORPHINE; PENTOBARBITAL; PHENOBARBITAL;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG SUBSTITUTION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INTENSIVE CARE UNITS, NEONATAL; MALE; MIDAZOLAM; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 33947359950     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2006.00156.x     Document Type: Article

References (19)

1. Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med 1999; 27: 196-9.
2. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA 2000; 283: 1451-9.
3. Tobias JD. Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use. Paediatr Drugs 1999; 1: 109-26.
4. Tobias JD. Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005; 34: 636-45.
5. Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med 2006; 8: 1125-36.
6. Twite MD, Rashid A, Zuk J, Friesen RH. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med 2004; 5: 521-32.
7. Prins S, van Dijk M, Tibboel D. Sedation and analgesia the PICU; many questions remain. Intensive Care Med 2006; 32: 1103-5.
8. de Wildt SN, de Hoog M, Vinks AA, Joosten KF, van Dijk M, van den Anker JN. Pharmacodynamics of midazolam in pediatric intensive care patients. Ther Drug Monit 2005; 27: 98-102.
9. van Dijk M, de Boer JB, Koot HM, Tibboel D, Passchier J, Duivenvoorden HJ. The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old infants. Pain 2000; 84: 367-77.
10. Tobias JD. Monitoring the depth of sedation in the pediatric ICU patient: where are we, or more importantly, where are our patients?*. Pediatr Crit Care Med 2005; 6: 715-8.
11. Crain N, Slonim A, Pollack MM. Assessing sedation in the pediatric intensive care unit by using BIS and the COMFORT scale. Pediatr Crit Care Med 2002; 3: 11-4.
12. Hartwig S, Roth B, Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur J Pediatr 1991; 150: 784-8.
13. Rosen DA, Rosen KR. Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med 1991; 17 (Suppl 1): S15-S19.8.
14. Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000; 28: 2122-32.
15. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001; 65: 21-37.
16. Andersen DL, Eckert AL, Tsai VW, Burke CJ, Tannenberg AE, Dodd PR. GABA(A) receptor sites in the developing human foetus. Brain Res Dev Brain Res 2002; 139: 107-19.
17. Chugani DC, Muzik O, Juhasz C, Janisse JJ, Ager J, Chugani HT. Postnatal maturation of human GABAA receptors measured with positron emission tomography. Ann Neurol 2001; 49: 618-26.
18. Porter BE, Zhang G, Celix J, Hsu FC, Raol YH, Telfeian A et al. Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients. Neurobiol Dis 2005; 18: 484-91.
19. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999; 37: 485-505.